Willow Biosciences Inc. (WLLW.TO) TSX
0.04
+0.005(+16.67%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Willow Biosciences Inc.
Address
202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
Phone
403 910 5140
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
19
First IPO Date
February 11, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Travis Doupe | Chief Financial Officer & Interim Chief Executive Officer | 300,475 | 1971 |
| Chris Savile | President, Director & Chief Executive Officer | 607,371 | N/A |
| Trish Choudhary | Senior Vice President of Research & Development | 453,896 | N/A |
| Sanjib Singh Gill | Corporate Secretary | 0 | 1976 |
Description
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
